The uptake of 3?-deoxy-3?-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels
Authors:
- 4 September 2004
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 32 (3) , 257-263
Abstract
Purpose The aim of this study was to investigate the role of thymidine kinase 1 (TK1) protein in 3′-deoxy-3′-[18F]fluorothymidine ([18F]FLT) positron emission tomography (PET) studies. Methods We investigated the in vivo kinetics of [18F]FLT in TK1+/− and TK1−/− L5178Y mouse lymphoma tumours that express different levels of TK1 protein. Results [18F]FLT-derived radioactivity, measured by a dedicated small animal PET scanner, increased within the tumours over 60 min. The area under the normalised tumour time–activity curve were significantly higher for the TK1+/− compared with the −/− variant (0.89±0.02 vs 0.79±0.03 MBq ml−1 min, P=0.043; n=5 for each tumour type). Ex vivo gamma counting of tissues excised at 60 min p.i. (n=8) also revealed significantly higher tumour [18F]FLT uptake for the TK1+/− variant (6.2±0.6 vs 4.6±0.4%ID g−1, P=0.018). The observed differences between the cell lines with respect to [18F]FLT uptake were in keeping with a 48% higher TK1 protein in the TK1+/− tumours versus the −/− variant (P=0.043). On average, there were no differences in ATP levels between the two tumour variants (P=1.00). A positive correlation between [18F]FLT accumulation and TK1 protein levels (r=0.68, P=0.046) was seen. Normalisation of the data for ATP content further improved the correlation (r=0.86, P=0.003). Conclusion This study shows that in vivo [18F]FLT kinetics depend on TK1 protein expression. ATP may be important in realising this effect. Thus, [18F]FLT-PET has the potential to yield specific information on tumour proliferation in diagnostic imaging and therapy monitoring.Keywords
This publication has 35 references indexed in Scilit:
- [ 18 F]FLT PET for diagnosis and staging of thoracic tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- An improved synthesis of 3′‐DEOXY‐3′‐[18F]fluorothymidine ([18F]FLT) and the fate of the precursor, 2, 3′‐anhydro‐5′‐O‐(4, 4′‐dimethoxytrityl)‐thymidineJournal of Labelled Compounds and Radiopharmaceuticals, 2001
- Imaging proliferation in vivo with [F-18]FLT and positron emission tomographyNature Medicine, 1998
- The use of L5178Y mouse lymphoma cells to assess the mutagenic, clastogenic and aneugenic properties of chemicalsMutagenesis, 1995
- Human thymidine kinase 1. Regulation in normal and malignant cellsAdvances in Enzyme Regulation, 1995
- Overexpression of human thymidine kinase mRNA without corresponding enzymatic activity in patients with chronic lymphatic leukemiaLeukemia Research, 1994
- Sequence analysis of tka-1 and tkb-1 alleles in L5178Y tk+/− mouse-lymphoma cells and spontaneous tk−/− mutantsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
- The HIV replication inhibitor 3′-fluoro-3′-deoxythymidine blocks sialylation of N-linked oligosaccharidesAntiviral Research, 1992
- Mutagenicity of 2-amino-N6-hydroxyadenine (AHA) at three loci in L5178Y/tk± mouse lymphoma cells: molecular and preliminary cytogenetic characterizations of AHA-induced tk−/− mutantsMutation Research/Environmental Mutagenesis and Related Subjects, 1991
- Thymidine kinase activity and trifluorothymidine resistance of spontaneous and mutagen-induced L5178Y cells in RPMI 1640 mediumMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1986